These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson's Disease. Galvagnion C J Parkinsons Dis; 2017; 7(3):433-450. PubMed ID: 28671142 [TBL] [Abstract][Full Text] [Related]
5. Synuclein Family Members Prevent Membrane Damage by Counteracting α-Synuclein Aggregation. Scheibe C; Karreman C; Schildknecht S; Leist M; Hauser K Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439733 [TBL] [Abstract][Full Text] [Related]
6. A Downsized and Optimised Intracellular Library-Derived Peptide Prevents Alpha-Synuclein Primary Nucleation and Toxicity Without Impacting Upon Lipid Binding. Meade RM; Watt KJC; Williams RJ; Mason JM J Mol Biol; 2021 Dec; 433(24):167323. PubMed ID: 34695381 [TBL] [Abstract][Full Text] [Related]
7. Anionic lipid vesicles have differential effects on the aggregation of early onset-associated α-synuclein missense mutants. Watt KJC; Meade RM; Williams RJ; Mason JM J Biol Chem; 2022 Dec; 298(12):102565. PubMed ID: 36208776 [TBL] [Abstract][Full Text] [Related]
8. Vesicle trafficking and lipid metabolism in synucleinopathy. Fanning S; Selkoe D; Dettmer U Acta Neuropathol; 2021 Apr; 141(4):491-510. PubMed ID: 32607605 [TBL] [Abstract][Full Text] [Related]
10. [The processes of α-synuclein amyloid protein complexes involved in the pathogenesis of Parkinson's disease]. Kiskis J; Horvath I; Wittung-Stafshede P; Rocha S Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(8):75-81. PubMed ID: 30251982 [TBL] [Abstract][Full Text] [Related]
11. Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α-synuclein. Rutherford NJ; Moore BD; Golde TE; Giasson BI J Neurochem; 2014 Dec; 131(6):859-67. PubMed ID: 24984882 [TBL] [Abstract][Full Text] [Related]
12. Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of α-synuclein. Galvagnion C; Brown JW; Ouberai MM; Flagmeier P; Vendruscolo M; Buell AK; Sparr E; Dobson CM Proc Natl Acad Sci U S A; 2016 Jun; 113(26):7065-70. PubMed ID: 27298346 [TBL] [Abstract][Full Text] [Related]
13. On the effect of methionine oxidation on the interplay between α-synuclein and synaptic-like vesicles. Uceda AB; Frau J; Vilanova B; Adrover M Int J Biol Macromol; 2023 Feb; 229():92-104. PubMed ID: 36584779 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the in vivo induction and transmission of α-synuclein pathology by mutant α-synuclein fibril seeds in transgenic mice. Rutherford NJ; Dhillon JS; Riffe CJ; Howard JK; Brooks M; Giasson BI Hum Mol Genet; 2017 Dec; 26(24):4906-4915. PubMed ID: 29036344 [TBL] [Abstract][Full Text] [Related]
15. Dynamic modeling of α-synuclein aggregation in dopaminergic neuronal system indicates points of neuroprotective intervention: experimental validation with implications for Parkinson's therapy. Sultana Z; Paleologou KE; Al-Mansoori KM; Ardah MT; Singh N; Usmani S; Jiao H; Martin FL; Bharath MM; Vali S; El-Agnaf OM Neuroscience; 2011 Dec; 199():303-17. PubMed ID: 22056602 [TBL] [Abstract][Full Text] [Related]
16. α-synuclein-assisted oligomerization of β-amyloid (1-42). Chau E; Kim JR Arch Biochem Biophys; 2022 Mar; 717():109120. PubMed ID: 35041853 [TBL] [Abstract][Full Text] [Related]